Showing results (131-140 of 662) with videos related to

Sort By:
Pageof 67
Rinsho Shinkeigaku = Clinical Neurology|January 27, 2012
[The diagnosis of neurodegenerative disorders based on clinical and pathological findings using an MRI approach]Hirohisa Watanabe, Mari Yoshida, Shinji Naganawa, et al.
Brain and Nerve = Shinkei Kenkyu No Shinpo|September 10, 2014
[Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS)]Naoki Atsuta, Ryoichi Nakamura, Hazuki Watanabe, et al.
Acta Neuropathologica|March 8, 2003
Clinical and neuropathological correlates of Lewy body diseaseNozomi Hishikawa, Yoshio Hashizume, Mari Yoshida, et al.
Expert Review of Neurotherapeutics|September 6, 2014
Potential therapeutic targets in polyglutamine-mediated diseasesMasahisa Katsuno, Hirohisa Watanabe, Masahiko Yamamoto, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 11, 2004
Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectivesMasahisa Katsuno, Hiroaki Adachi, Fumiaki Tanaka, et al.
Rinsho Shinkeigaku = Clinical Neurology|December 25, 2009
[Exploration of pathogenesis and therapy development for ALS employing sporadic disease model]Fumiaki Tanaka, Masahiro Waza, Masahiko Yamamoto, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|January 17, 2012
Lewy body-related α-synucleinopathy in the spinal cord of cases with incidental Lewy body diseaseTakuya Tamura, Mari Yoshida, Yoshio Hashizume, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|June 3, 2009
Pathogenesis-targeting therapeutics for spinal and bulbar muscular atrophy (SBMA)Keisuke Suzuki, Masahisa Kastuno, Haruhiko Banno, et al.
Rinsho Shinkeigaku = Clinical Neurology|December 3, 2013
[Dysfunction of dynactin 1 in motor neuron degeneration]Masahisa Katsuno, Kensuke Ikenaka, Kaori Kawai, et al.
Pageof 67